PTAB Decision to Institute IPR Excluded From Trial

Jul 26, 2015

Reading Time : 1 min

In granting plaintiff’s motion in limine, the court relied on the difference in standards – “a reasonable likelihood that the petitioner would prevail” contrasted with the “clear and convincing” standard. The court also noted that after the Patent Trial and Appeal Board (PTAB) instituted inter partes review, the non­party petitioner settled and the inter partes review proceeding was dismissed, without the PTAB rendering a decision. The court further noted that the evidence would be confusing to the jury and prejudicial to plaintiffs without a “time­consuming explanation of the PTAB procedures.” “Telling the jury that the patent has been called into question by the Patent Office may influence the jury’s application of the presumption of validity and prejudice [plaintiff].” The court concluded that the prejudicial potential of the evidence substantially outweighed any probative value.

Ivera Medical Corporation et al v. Hospira, Inc., 3­14­cv­01345 (S.D. Cal. July 21, 2015, Order) (Huff, J.).

Share This Insight

Previous Entries

IP Newsflash

December 5, 2025

District courts are split on whether a complaint can provide the required knowledge for post-suit indirect and willful infringement in that same lawsuit. Chief Judge Connolly in the District of Delaware recently confirmed that, consistent with his prior opinions, the complaint cannot serve as the basis for knowledge for either a claim of post-suit indirect infringement or a demand for willfulness-based enhanced damages in that lawsuit.

...

Read More

IP Newsflash

December 3, 2025

The Federal Circuit recently held that a patentee acted as its own lexicographer to define a claim term even though it did not explicitly define the term. Rather, because the patentee consistently and clearly used two terms interchangeably to describe the same structural feature and did so in all of the embodiments in which the feature appeared, the patentee impliedly gave the term its own, unique definition.

...

Read More

IP Newsflash

December 2, 2025

The Federal Circuit recently held an asserted patent was not entitled to its priority date because the priority application lacked written description support for the asserted claims. In so doing, the court explained that broad disclosures that do not provide reasonably specific support for narrower claims do not meet the written description requirement. The court also considered whether the inventor’s testimony showed they possessed the full scope of the claimed genus at the priority date or whether it was more likely the inventors first became aware of the claimed embodiments from public disclosures of the accused product.

...

Read More

IP Newsflash

December 1, 2025

In a Hatch-Waxman case, the District of Delaware denied a motion for summary judgment seeking to apply the ANDA filing date as the date of the hypothetical negotiation used to calculate reasonable royalty damages. Instead, the court determined that the appropriate date to use for the hypothetical negotiation is the launch date.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.